GlassScriptPhysician profile
Anjali Jain
NPI 1568470797
$2,764.06
in general payments reported to CMS, 2019-2025
19 companies · $264 in 2025
The $264 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $305 · 2021: $265 · 2022: $1,168 · 2023: $364 · 2024: $279 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $907.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $907.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $981.12 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $666.45 | 2019-2025 | Relistor, Trulance |
| Medtronic, INC. | $225.23 | 2021-2023 | Intellis Adaptivestim |
| Medtronic USA, INC. | $135.98 | 2020 | |
| Revance Therapeutics, INC. | $135.25 | 2024-2025 | Daxi, Daxxify |
| Curonix LLC | $97.95 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Collegium Pharmaceutical, INC. | $80.07 | 2019-2021 | |
| Pfizer INC. | $75.55 | 2019-2021 | |
| Galderma Laboratories, L.P. | $71.73 | 2024 | |
| Globus Medical, INC. | $62.56 | 2025 | Senza |
| Ipsen Biopharmaceuticals, INC | $56.63 | 2024 | Dysport |
| Mdd US Operations, LLC | $40.88 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $29.96 | 2025 | |
| Scilex Pharmaceuticals INC. | $27.96 | 2021 | |
| Merz Pharmaceuticals, LLC | $17.91 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $17.21 | 2019 | |
| Virtus Pharmaceuticals LLC | $14.82 | 2021 | |
| Fidia Pharma USA INC. | $13.43 | 2024 | Hymovis, Hyalgan, Triluron |
| Orthofix Medical, INC. | $13.37 | 2023 | Spinal-Stim, Spinal-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anjali Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.